Optimized Heptamethine Cyanines for Photodynamic Therapy

Area of Science:

• Biomedical Engineering
• Photochemistry
• Oncology

Background:

• Photodynamic therapy (PDT) is a promising cancer treatment modality.
• Current PDT sensitizers have limitations, including limited tissue penetration due to absorption in the visible light spectrum.

Purpose of the Study:

• To develop novel near-infrared (NIR) fluorescent sensitizers for enhanced photodynamic therapy (PDT).
• To optimize sensitizer properties for improved tumor localization, singlet oxygen generation, and cellular uptake.

Main Methods:

• Synthesis of over 10 novel cyanine-based NIR fluorescent sensitizers.
• Characterization of photophysical properties, including excitation wavelength (~800 nm) and singlet oxygen quantum yields.
• Evaluation of cellular uptake mechanisms via organic anion transporter proteins (OATPs) and assessment of photocytotoxicity in cancer cells.

Main Results:

• Developed NIR sensitizers excitable around 800 nm with favorable hydrophilic properties.
• Achieved acceptable singlet oxygen generation quantum yields.
• Demonstrated efficient import into cancer cells mediated by OATPs, crucial for tumor localization.
• Optimized photocytotoxicity by modifying N-substituents without compromising other key characteristics.
• Observed superior characteristics compared to clinically approved sensitizers, particularly in terms of tissue penetration depth.

Conclusions:

• Novel NIR fluorescent sensitizers exhibit significant potential for advanced photodynamic therapy applications.
• The developed compounds offer improved tumor targeting and deeper tissue penetration, overcoming limitations of current PDT agents.
• Further development of these sensitizers could lead to more effective and safer cancer treatment strategies.